| Application no. and date | 21733318.6 (espacenet) (Federated) (European Patent Register), 20210526 | | Patent/reg. no. and date | DK/EP 4157832, 20240619 | | Publication date | 20230405 | | Priority no. and date | WO PCT/CN2020/092530, 20200527 | | EP pub. no. and date |
EP 4157832 20230405 | | Effective date | | | Applicant/owner | Qilu Regor Therapeutics Inc., Building 10
No. 1206, Zhangjiang Road
Shanghai 201210, CN | | Applicant ref. no. | PE962316DKQ | | Inventor | ZHONG, Wenge,
Thousand Oaks, CA 91362, US,
CHEN, Beibei,
Hangzhou Bay New Zone Ningbo Zhejiang, 315336, CN,
WEI, Xudong,
Coventry, Rhode Island 02816, US,
JIANG, Meng,
Suzhou Jiangsu, 215123, CN | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | C07D 405/14 (2006.01) | | Title | SALT AF KRYSTALFORMER AF GLP-1R-AGONISTER OG ANVENDELSER DERAF | | Int. application no. | US2021034191 | | Int. publication no. | WO2021242817 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
